Results 261 to 270 of about 36,741 (290)

Patient adherence and persistence with oral anticancer treatment

Ca-A Cancer Journal for Clinicians, 2009
Kathryn J Ruddy, Ann H Partridge
exaly  

[Oral hypoglycemic agents].

Resenha clinico-cientifica, 2000
P P, FOA, G, GALANSINO
  +6 more sources

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William M Lydiatt, Snehal G Patel, Brian O'Sullivan   +2 more
exaly  

Oral hypoglycemic agents.

Geriatrics, 1967
J F, Seidensticker, G J, Hamwi
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Oral hypoglycemic agents.

Advances in internal medicine, 1979
T, Boyden, R, Bressler
openaire   +1 more source

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Oral Hypoglycemic Agents: Panel Discussion

Diabetes, 1958
Arthur R Colwell, Henry Dolger, Rachmiel Levine, Garfield G Duncan, Mary A Root   +4 more
openaire   +2 more sources